Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43


Time trends of period prevalence rates of patients with inhaled long-acting beta-2-agonists-containing prescriptions: a European comparative database study.

Rottenkolber M, Voogd E, van Dijk L, Primatesta P, Becker C, Schlienger R, de Groot MC, Alvarez Y, Durand J, Slattery J, Afonso A, Requena G, Gil M, Alvarez A, Hesse U, Gerlach R, Hasford J, Fischer R, Klungel OH, Schmiedl S.

PLoS One. 2015 Feb 23;10(2):e0117628. doi: 10.1371/journal.pone.0117628. eCollection 2015.


Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry.

Tilson H, Primatesta P, Kim D, Rauer B, Hawkins PN, Hoffman HM, Kuemmerle-Deschner J, van der Poll T, Walker UA.

Orphanet J Rare Dis. 2013 Sep 10;8:139. doi: 10.1186/1750-1172-8-139.


Sizable variations in circulatory disease mortality by region and country of birth in six European countries.

Rafnsson SB, Bhopal RS, Agyemang C, Fagot-Campagna A, Harding S, Hammar N, Hedlund E, Juel K, Primatesta P, Rosato M, Rey G, Wild SH, Mackenbach JP, Stirbu I, Kunst AE.

Eur J Public Health. 2013 Aug;23(4):594-605. doi: 10.1093/eurpub/ckt023. Epub 2013 Mar 11.


Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease.

Rothenbacher D, Kleiner A, Koenig W, Primatesta P, Breitling LP, Brenner H.

PLoS One. 2012;7(9):e45907. doi: 10.1371/journal.pone.0045907. Epub 2012 Sep 21.


Mortality from circulatory diseases by specific country of birth across six European countries: test of concept.

Bhopal RS, Rafnsson SB, Agyemang C, Fagot-Campagna A, Giampaoli S, Hammar N, Harding S, Hedlund E, Juel K, Mackenbach JP, Primatesta P, Rey G, Rosato M, Wild S, Kunst AE.

Eur J Public Health. 2012 Jun;22(3):353-9. doi: 10.1093/eurpub/ckr062. Epub 2011 May 20.


Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.

Primatesta P, Plana E, Rothenbacher D.

BMC Musculoskelet Disord. 2011 May 20;12:103. doi: 10.1186/1471-2474-12-103.


Frequency and risk factors of gout flares in a large population-based cohort of incident gout.

Rothenbacher D, Primatesta P, Ferreira A, Cea-Soriano L, Rodríguez LA.

Rheumatology (Oxford). 2011 May;50(5):973-81. doi: 10.1093/rheumatology/keq363. Epub 2011 Jan 12.


Ethnic inequalities in access to and outcomes of healthcare: analysis of the Health Survey for England.

Nazroo JY, Falaschetti E, Pierce M, Primatesta P.

J Epidemiol Community Health. 2009 Dec;63(12):1022-7. doi: 10.1136/jech.2009.089409. Epub 2009 Jul 20.


Cardiovascular medication, physical activity and mortality: cross-sectional population study with ongoing mortality follow-up.

Stamatakis E, Hamer M, Primatesta P.

Heart. 2009 Mar;95(6):448-53. doi: 10.1136/hrt.2008.152041. Epub 2008 Sep 18.


Cardiovascular surveys: manual of operations.

Primatesta P, Allender S, Ciccarelli P, Doring A, Graff-Iversen S, Holub J, Panico S, Trichopoulou A, Verschuren WM; EUROCISS Research Group.

Eur J Cardiovasc Prev Rehabil. 2007 Dec;14 Suppl 3:S43-61. doi: 10.1097/01.hjr.0000277988.18096.3b. Review.


Self-reported never-drinkers in England 1994-2003: characteristics and trends in adults aged 18-54 years.

Pattenden S, Nanchahal K, Primatesta P, Thom B.

Alcohol Alcohol. 2008 Jan-Feb;43(1):91-6. Epub 2007 Oct 12.


Generalised and abdominal obesity and risk of diabetes, hypertension and hypertension-diabetes co-morbidity in England.

Hirani V, Zaninotto P, Primatesta P.

Public Health Nutr. 2008 May;11(5):521-7. Epub 2007 Sep 4.


Domestic physical activity in relationship to multiple CVD risk factors.

Stamatakis E, Hillsdon M, Primatesta P.

Am J Prev Med. 2007 Apr;32(4):320-327.


Response to Tomsak, R. PDE5 inhibitors and permanent visual loss (Int J Impot Res 2005; 17: 547-549).

Watt SJ, Primatesta P, Siegel R.

Int J Impot Res. 2006 Jul-Aug;18(4):411; author reply 412. No abstract available.


Overweight and obesity trends from 1974 to 2003 in English children: what is the role of socioeconomic factors?

Stamatakis E, Primatesta P, Chinn S, Rona R, Falascheti E.

Arch Dis Child. 2005 Oct;90(10):999-1004. Epub 2005 Jun 14.


Guidelines and risk factor management.

Primatesta P.

Heart. 2005 Apr;91(4):417-8.


An international comparative study of blood pressure in populations of European vs. African descent.

Cooper RS, Wolf-Maier K, Luke A, Adeyemo A, Banegas JR, Forrester T, Giampaoli S, Joffres M, Kastarinen M, Primatesta P, Stegmayr B, Thamm M.

BMC Med. 2005 Jan 5;3:2.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk